(1 - 6 von 6
)
“ICH GCP Goes Risk-Based” | PPH plus
pph-plus.com
Three co-founders of the RbM Consortium, Dr. María Proupín-Pérez (PPH plus, Germany), Dr. Artem Andrianov (Cyntegrity, Germany), and Dr. Beat Widler (Widler & Schiemann, Switzerland), examine how the draft addendum to the ICH GCP guideline (E6) will change clinical research in their new article “ICH GCP Goes Risk-Based” (Applied Clinical Trials Online, 20 October 2015).The
ACRES network gathers pace with Executive Office - PharmaTimes
www.pharmatimes.com
Fellow co-founders Beat Widler, managing partner at Widler and Schiemann and former global head of quality for Hoffmann-La Roche, and ...
sortiert nach Relevanz / Datum